Clinical Significance of Elevated Levels of Soluble‐Form Immune Checkpoint Molecules in Patients With Aggressive Adult T‐Cell Leukemia‐Lymphoma
ABSTRACT Background Immune checkpoint (IC) pathways, including programmed death protein 1 (PD‐1), its ligand PD‐L1, and CTLA‐4, mediate negative regulatory signals in immune responses. Recent studies in autoimmune diseases and malignancies reported that the presence of the soluble form of these ICs...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2025-08-01
|
| Saila: | eJHaem |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/jha2.70046 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|